Gestational diabetes, glycemic management trajectories, and offspring growth patterns and obesity risk
Chehab RF, Greenberg MB, Lee C, et al.
Diabetes Care. Pub. online 4 Mar 2026.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Comparative effectiveness of tirzepatide versus dulaglutide or semaglutide on major cardiovascular events in type 2 diabetes and cardiovascular disease: insights from two target-trial emulations
Ostrominski JW, Ortega-Montiel J, Wexler DJ, et al.
Diabetes Care. Pub. online 2 Mar 2026.
Leggi
Semaglutide in peripheral artery disease and diabetes by baseline disease severity and age: the STRIDE trial
Nordanstig J, Arslan EG, Catarig AM, et al.
Eur Heart J. Pub. online 5 Mar 2026.
Leggi
Everyone or just some? cost-effectiveness of general population versus targeted screening strategies for type 1 diabetes in Canada
Mital S, Schatz DA, Haller MJ, et al.
Diabetes Care. Pub. online 2 Mar 2026.
Leggi
Small extracellular vesicle external surface adiponectin-mediated adipocytes/cardiomyocytes communication in diabetic ischemic heart failure
Zhang Z, Zhu D, Liu C, et al.
Circulation. Pub. online 2 Mar 2026.
Leggi
Finerenone in type 1 diabetes and chronic kidney disease
Heerspink HJL, Birkenfeld AL, Cherney DZI, et al.
N Engl J Med. Pub. online 5 Mar 2026.
Leggi
Obesity and metabolic syndrome predict polyneuropathy over 5 years in recent-onset type 2 diabetes and normal glucose tolerance
Sipola G, Strom A, Wagner R, et al.
Diabetes Metab Res Rev. Pub. online 3 Mar 2026.
Leggi
Additive cardiorenal benefits of finerenone and SGLT2 inhibitor combination therapy in diabetic CKD: a propensity-matched real-world study
Mortada I, Lee A, Sahu A, et al.
Am J Cardiol. Pub. online 27 Feb 2026.
Leggi
Impact of early and tight HbA1c control on the risk of long-term complications and cardiovascular death in patients with type 2 diabetes from the Swedish National Diabetes Register
Mount J, Boye K, Lebrec J, Wilkes E, et al.
Diabetes Obes Metab. Pub. online 27 Feb 2026.
Leggi
Sodium-glucose co-transporter 2 inhibitors and obesity-associated cancers in people with type 2 diabetes: a real-world observational study
Ipaye T, Goldney J, Yates T, et al.
Diabetes Obes Metab. Pub. online 26 Feb 2026.
Leggi